The global aerosol delivery devices market size was US$ 14.5 billion in 2021. The global aerosol delivery devices market is forecast to grow to US$ 21.1 billion by 2030 by growing at a compound annual ...

Chronic Obstructive Pulmonary Disease (COPD) Devices Market By Product Type (Inhalers, Nebulizers, Oxygen Therapy Devices, Others), By End-use (Hospitals, Homecare Settings), By Region Forecast to ...

), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The Food and Drug Administration (FDA) recently cleared ResMed's home ...

Please provide your email address to receive an email when new articles are posted on . Available studies on wearable devices and COPD exacerbations have differing data collection methods. Patient ...

INDIANAPOLIS (WISH) — About 12.5 million Americans have chronic obstructive pulmonary disease, or COPD. With COPD, the air sacs in the lungs are damaged, obstructing their ability to stretch and ...

Biosency SAS recently unveiled the latest results on its predictive digital medical device for remote monitoring of patient suffering from chronic obstructive pulmonary disease (COPD). The Bora ...

The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...

Obstructive sleep apnoea hypopnoea syndrome (OSAHS) is a condition in which the upper airway becomes blocked repeatedly during sleep. This can intermittently reduce airflow (hypopnoea) or stop airflow ...